Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Sales (2018 - 2025)

Catalyst Pharmaceuticals' Return on Sales history spans 12 years, with the latest figure at 0.35% for Q4 2025.

  • For Q4 2025, Return on Sales rose 2.0% year-over-year to 0.35%; the TTM value through Dec 2025 reached 0.36%, up 5.0%, while the annual FY2025 figure was 0.36%, 5.0% up from the prior year.
  • Return on Sales reached 0.35% in Q4 2025 per CPRX's latest filing, down from 0.36% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.71% in Q4 2022 to a low of 0.3% in Q3 2023.
  • Average Return on Sales over 5 years is 0.31%, with a median of 0.34% recorded in 2021.
  • Peak YoY movement for Return on Sales: tumbled -119bps in 2021, then surged 64bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.24% in 2021, then surged by 193bps to 0.71% in 2022, then tumbled by -78bps to 0.15% in 2023, then skyrocketed by 113bps to 0.33% in 2024, then rose by 5bps to 0.35% in 2025.
  • Per Business Quant, the three most recent readings for CPRX's Return on Sales are 0.35% (Q4 2025), 0.36% (Q3 2025), and 0.36% (Q2 2025).